Lantern Pharma Inc. Cash Equivalents, at Carrying Value
Lantern Pharma Inc. (LTRN) had Cash Equivalents, at Carrying Value of $5.28 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash Equivalents, at Carrying Value $5.28M.
- 2026-03-31: Cash Equivalents, at Carrying Value $2.53M.
- 2025-12-31: Cash Equivalents, at Carrying Value $1.54M; Cash Equivalents, at Carrying Value as first filed $1.54M.
- 2025-09-30: Cash Equivalents, at Carrying Value $6.28M.
| Period end | Cash Equivalents, at Carrying Value | Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $5.28M 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $2.53M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $1.54M 10-Q · filed 2026-08-14 | $1.54M 10-K · filed 2026-03-30 |
| 2025-09-30 | $6.28M 10-Q · filed 2025-11-12 | |
| 2025-06-30 | $4.62M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $5.51M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $6.62M 10-K · filed 2026-03-30 | $6.62M 10-K · filed 2025-03-27 |
| 2024-09-30 | $6.97M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $11.51M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $16.69M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | $20.88M 10-K · filed 2025-03-27 | |
| 2023-09-30 | $24.28M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $25.39M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $17.24M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $1.27M 10-K · filed 2024-03-18 | |
| 2021-12-31 | $631.00K 10-K · filed 2023-03-20 | |
| 2021-09-30 | $768.00K 10-Q · filed 2021-11-01 | |
| 2021-06-30 | $1.67M 10-Q · filed 2021-07-29 | |
| 2020-12-31 | $0.00 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B | |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| ACTUATE THERAPEUTICS, INC. (ACTU) | United States | $0.015B | |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |